• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.62%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    376.71 Down 14.59(3.73%) Apr 29, 4:00PM EDT
    |After Hours : 377.79 Up 1.08 (0.29%) Apr 29, 7:51PM EDT
    Prev Close:391.30
    Open:388.63
    Bid:374.62 x 100
    Ask:378.15 x 1000
    1y Target Est:475.95
    Beta:1.55676
    Next Earnings Date: 5-May-16REGN Earnings announcement
    Day's Range:373.14 - 393.00
    52wk Range:348.96 - 605.93
    Volume:889,597
    Avg Vol (3m):970,169
    Market Cap:39.42B
    P/E (ttm):68.24
    EPS (ttm):5.52
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    REGNDown 3.73%39.42B
    AMGNDown 1.41%118.73B

    Key Statistics

    Forward P/E (1 yr):23.10
    P/S (ttm):9.93
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :11.53
    Quarterly EPS Est (Mar-16) :2.61
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):1.58

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback